Page last updated: 2024-08-21

oleanolic acid and Cardiovascular Diseases

oleanolic acid has been researched along with Cardiovascular Diseases in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's15 (93.75)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Chen, WH; Chen, X; Hou, N; Li, D; Lu, YJ; Sun, N; Wong, WL; Wu, P1
Jiang, H; Sun, A1
Ferriol, P; Monserrat-Mesquida, M; Pinya, S; Sureda, A; Tejada, S1
Kim, BM1
Gamede, M; Khathi, A; Mabuza, L; Ngubane, P1
Akizawa, T; Audhya, P; Bakris, GL; Chertow, GM; Christ-Schmidt, H; de Zeeuw, D; Goldsberry, A; Krauth, M; Lambers Heerspink, HJ; Linde, P; McMurray, JJ; Meyer, CJ; Parving, HH; Remuzzi, G; Toto, RD; Vaziri, ND; Wanner, C; Wittes, J; Wrolstad, D1
Himmelfarb, J; Tuttle, KR2
Akizawa, T; Audhya, P; Bakris, GL; Chertow, GM; Chin, M; Christ-Schmidt, H; de Zeeuw, D; Goldsberry, A; Houser, M; Krauth, M; Lambers Heerspink, HJ; McMurray, JJ; Meyer, CJ; Parving, HH; Remuzzi, G; Toto, RD; Vaziri, ND; Wanner, C; Wittes, J; Wrolstad, D1
Chertow, GM; de Zeeuw, D1
Chartoumpekis, DV; Sykiotis, GP1
Kovács, T; Molnár, GA; Wittmann, I1
Ellison, DH1
Van Biesen, W; Van Laecke, S; Vanholder, R1
de Zeeuw, D; Meyer, C1
Rodriguez-Rodriguez, R1

Reviews

4 review(s) available for oleanolic acid and Cardiovascular Diseases

ArticleYear
New Applications of Oleanolic Acid and its Derivatives as Cardioprotective Agents: A Review of their Therapeutic Perspectives.
    Current pharmaceutical design, 2019, Volume: 25, Issue:35

    Topics: Cardiotonic Agents; Cardiovascular Diseases; Humans; Oleanolic Acid

2019
Hypotensive Effects of the Triterpene Oleanolic Acid for Cardiovascular Prevention.
    Current molecular pharmacology, 2021, Volume: 14, Issue:6

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Oleanolic Acid; Triterpenes

2021
The Role of Saikosaponins in Therapeutic Strategies for Age-Related Diseases.
    Oxidative medicine and cellular longevity, 2018, Volume: 2018

    Topics: Apoptosis; Cardiovascular Diseases; Cell Cycle Checkpoints; Humans; Liver Diseases; Neoplasms; Neurodegenerative Diseases; Obesity; Oleanolic Acid; Oxidative Stress; Saponins

2018
Oleanolic acid and related triterpenoids from olives on vascular function: molecular mechanisms and therapeutic perspectives.
    Current medicinal chemistry, 2015, Volume: 22, Issue:11

    Topics: Animals; Cardiovascular Diseases; Humans; Molecular Conformation; Olea; Oleanolic Acid; Triterpenes

2015

Trials

2 trial(s) available for oleanolic acid and Cardiovascular Diseases

ArticleYear
Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:11

    Topics: Adolescent; Adult; Aged; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Oleanolic Acid; Prognosis; Renal Insufficiency, Chronic; Young Adult

2013
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
    The New England journal of medicine, 2013, 12-26, Volume: 369, Issue:26

    Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; NF-E2-Related Factor 2; Oleanolic Acid; Renal Insufficiency, Chronic; Treatment Failure; Weight Loss

2013

Other Studies

10 other study(ies) available for oleanolic acid and Cardiovascular Diseases

ArticleYear
Novel Findings and Therapeutic Targets in Cardioprotection.
    Current pharmaceutical design, 2019, Volume: 25, Issue:35

    Topics: Aging; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Humans; Myocardial Infarction; Oleanolic Acid

2019
Plant-Derived Oleanolic Acid (OA) Ameliorates Risk Factors of Cardiovascular Diseases in a Diet-Induced Pre-Diabetic Rat Model: Effects on Selected Cardiovascular Risk Factors.
    Molecules (Basel, Switzerland), 2019, Jan-18, Volume: 24, Issue:2

    Topics: Animals; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cytokines; Diabetes Mellitus, Experimental; Diet, High-Fat; Disease Models, Animal; Fasting; Inflammation Mediators; Oleanolic Acid; Oxidative Stress; Plant Extracts; Prediabetic State; Rats; Risk Factors

2019
New therapies for diabetic kidney disease.
    The New England journal of medicine, 2013, Dec-26, Volume: 369, Issue:26

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic

2013
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
    The New England journal of medicine, 2014, 05-01, Volume: 370, Issue:18

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic

2014
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
    The New England journal of medicine, 2014, 05-01, Volume: 370, Issue:18

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic

2014
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
    The New England journal of medicine, 2014, 05-01, Volume: 370, Issue:18

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic

2014
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
    The New England journal of medicine, 2014, 05-01, Volume: 370, Issue:18

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic

2014
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.
    The New England journal of medicine, 2014, 05-01, Volume: 370, Issue:18

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic

2014
The paradox of bardoxolone methyl: a call for every witness on the stand?
    Diabetes, obesity & metabolism, 2015, Volume: 17, Issue:1

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic

2015
The paradox created by commenting on large clinical trial results.
    Diabetes, obesity & metabolism, 2015, Volume: 17, Issue:1

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Oleanolic Acid; Renal Insufficiency, Chronic

2015